Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study

<h3>Background</h3><p dir="ltr">Acute pancreatitis (AP) is a rare but serious complication of intragastric balloon (IGB) therapy. Despite the popularity of IGBs for weight loss, the incidence and risk factors of AP post-IGB insertion are not well understood. This study ai...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Yousef Yahia (19756989) (author)
مؤلفون آخرون: Joud Abuodeh (14777671) (author), Prem Chandra (9072038) (author), Ethar Mohamed (19756992) (author), Anas Zayad (22302712) (author), Leen AbuAfifeh (22302715) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513513490219008
author Yousef Yahia (19756989)
author2 Joud Abuodeh (14777671)
Prem Chandra (9072038)
Ethar Mohamed (19756992)
Anas Zayad (22302712)
Leen AbuAfifeh (22302715)
author2_role author
author
author
author
author
author_facet Yousef Yahia (19756989)
Joud Abuodeh (14777671)
Prem Chandra (9072038)
Ethar Mohamed (19756992)
Anas Zayad (22302712)
Leen AbuAfifeh (22302715)
author_role author
dc.creator.none.fl_str_mv Yousef Yahia (19756989)
Joud Abuodeh (14777671)
Prem Chandra (9072038)
Ethar Mohamed (19756992)
Anas Zayad (22302712)
Leen AbuAfifeh (22302715)
dc.date.none.fl_str_mv 2025-01-14T09:00:00Z
dc.identifier.none.fl_str_mv 10.1007/s11695-024-07647-x
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Risk_Factors_for_Acute_Pancreatitis_Following_Intragastric_Balloon_Insertion_A_7-Year_Retrospective_Cohort_Study/30196963
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Intragastric balloon
Acute pancreatitis
Obesity
Weight loss
Risk factors
Complications
Orbera balloon
dc.title.none.fl_str_mv Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">Acute pancreatitis (AP) is a rare but serious complication of intragastric balloon (IGB) therapy. Despite the popularity of IGBs for weight loss, the incidence and risk factors of AP post-IGB insertion are not well understood. This study aimed to identify potential predictors and risk factors of AP in IGB patients.</p><h3>Methods</h3><p dir="ltr">A retrospective time-to-event study was conducted over 7 years, encompassing patients who received IGBs between January 2017 and 2024. Cox regression analyses were performed to identify risk factors. The incidence of AP was evaluated as a secondary outcome. Patients were categorized into the AP and non-AP groups at a 1:3 ratio. The Revised Atlanta Classification was used to diagnose AP.</p><h3>Results</h3><p dir="ltr">Among 450 patients with IGB, 25 developed AP, yielding an incidence of 5.56%. The Orbera balloon was associated with a lower AP risk (HR 0.29, 95% CI: 0.09–0.96; P = 0.042). The median time to AP onset was 40 days. Higher preprocedural BMI and age > 30 years showed a trend toward reduced AP risk, though not statistically significant.</p><h3>Conclusions</h3><p dir="ltr">AP following IGB insertion is uncommon but may be underreported, with substantial variability in onset time. The Orbera balloon demonstrated a protective effect, highlighting the role of balloon type in AP risk. These findings underscore the importance of balloon selection and the need for further prospective studies to confirm these results and optimize AP risk management in IGB patients.</p><h2>Other Information</h2><p dir="ltr">Published in: Obesity Surgery<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s11695-024-07647-x" target="_blank">https://dx.doi.org/10.1007/s11695-024-07647-x</a></p>
eu_rights_str_mv openAccess
id Manara2_a7bd322a4aa7cd6c0c4ad35e16cbe246
identifier_str_mv 10.1007/s11695-024-07647-x
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/30196963
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort StudyYousef Yahia (19756989)Joud Abuodeh (14777671)Prem Chandra (9072038)Ethar Mohamed (19756992)Anas Zayad (22302712)Leen AbuAfifeh (22302715)Biomedical and clinical sciencesClinical sciencesIntragastric balloonAcute pancreatitisObesityWeight lossRisk factorsComplicationsOrbera balloon<h3>Background</h3><p dir="ltr">Acute pancreatitis (AP) is a rare but serious complication of intragastric balloon (IGB) therapy. Despite the popularity of IGBs for weight loss, the incidence and risk factors of AP post-IGB insertion are not well understood. This study aimed to identify potential predictors and risk factors of AP in IGB patients.</p><h3>Methods</h3><p dir="ltr">A retrospective time-to-event study was conducted over 7 years, encompassing patients who received IGBs between January 2017 and 2024. Cox regression analyses were performed to identify risk factors. The incidence of AP was evaluated as a secondary outcome. Patients were categorized into the AP and non-AP groups at a 1:3 ratio. The Revised Atlanta Classification was used to diagnose AP.</p><h3>Results</h3><p dir="ltr">Among 450 patients with IGB, 25 developed AP, yielding an incidence of 5.56%. The Orbera balloon was associated with a lower AP risk (HR 0.29, 95% CI: 0.09–0.96; P = 0.042). The median time to AP onset was 40 days. Higher preprocedural BMI and age > 30 years showed a trend toward reduced AP risk, though not statistically significant.</p><h3>Conclusions</h3><p dir="ltr">AP following IGB insertion is uncommon but may be underreported, with substantial variability in onset time. The Orbera balloon demonstrated a protective effect, highlighting the role of balloon type in AP risk. These findings underscore the importance of balloon selection and the need for further prospective studies to confirm these results and optimize AP risk management in IGB patients.</p><h2>Other Information</h2><p dir="ltr">Published in: Obesity Surgery<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s11695-024-07647-x" target="_blank">https://dx.doi.org/10.1007/s11695-024-07647-x</a></p>2025-01-14T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s11695-024-07647-xhttps://figshare.com/articles/journal_contribution/Risk_Factors_for_Acute_Pancreatitis_Following_Intragastric_Balloon_Insertion_A_7-Year_Retrospective_Cohort_Study/30196963CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/301969632025-01-14T09:00:00Z
spellingShingle Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
Yousef Yahia (19756989)
Biomedical and clinical sciences
Clinical sciences
Intragastric balloon
Acute pancreatitis
Obesity
Weight loss
Risk factors
Complications
Orbera balloon
status_str publishedVersion
title Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
title_full Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
title_fullStr Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
title_full_unstemmed Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
title_short Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
title_sort Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study
topic Biomedical and clinical sciences
Clinical sciences
Intragastric balloon
Acute pancreatitis
Obesity
Weight loss
Risk factors
Complications
Orbera balloon